Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus?

Hervé M. Richet, Mohamed Benbachir, Derek F.J. Brown, Helen Giamarellou, Ian Gould, Marija Gubina, Piotr Heczko, Smilja Kalenic, Marina Pana, Didier Pittet, Saida Ben Redjeb, Jiri Schindler, Carlos Starling, Marc J. Struelens, Wolfgang Witte, William R. Jarvis, Horacio Lopardo, Manfred Rotter, Marc Struelens, Maja OstjicJorge Saliba, Boyka Markova, Kwok Yung Yuen, Mireille Dosso, Ines Bencic, Nastja Kucisec-Tepes, Jasenta Skrlin, Edita Susic, Maja Tomic, D. Burgetova, Andre-Richet, D. Barraud, Besnard, Edouard Bichier, M. Bingen, Catherine Branger, Anne Cirioni, Stephanie Clavel, Simone Clévenot, Andréa Collet, François Coulomb, Patrice Courvalin, Armelle David, François Denis, Marie Cécile Ploy, Jean Yves Esvant, Ferrant, Annick Genuis, Guir, Didier Jan, Françoise Jezequel, Jean Louis Laborie, Florence Le Gallou, Lemoign, Christine Rennes, Pascale Richard, Yveline Ruellan, Jacques Vaucel, Liliane Zbierski, Barbel Christiansen, Julia Fitzner, Mathias Hermann, Michael Kramer, Werner Mathys, Sabine Schubert, Stefan Weber, A. Katrachoura, E. A. Papafrangas, Danae Sofianou, Anna Marton, Nathan Keller, Ethan Rubinstein, Giuseppe Cornaglia, Jurjis Perevostikos, Ivonna Selga, Robert Hemmer, M. A. Alaoui, A. Benouda-Benjilaji, J. H.T. Wagenvoort, M. Pytlos, Waleria Hryniewicz, Manuela Anda Andrei, Dana Andries, Daniela Blana, Lucia Debeleac, Olga Dorobat, Antonia Medvetchi-Panatescu, Irina Nistor, Raluca Papagheorge, Elena Silaghi, Daniela Tudorache, Andrei Dekhitch, Leonid Stratchounski, S. B.Cheikh Boye, Katja Seme, Javier Garau, Ferran Navarro, Guillem Prats, Antoni Trilla

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

OBJECTIVE: To assess the way healthcare facilities (HCFs) diagnose, survey, and control methicillin-resistant Staphylococcus aureus (MRSA). DESIGN: Questionnaire. SETTING: Ninety HCFs in 30 countries. RESULTS: Evaluation of susceptibility testing methods showed that 8 laboratories (9%) used oxacillin disks with antimicrobial content different from the one recommended, 12 (13%) did not determine MRSA susceptibility to vancomycin, and 4 (4.5%) reported instances of isolation of vancomycin-resistant S. aureus but neither confirmed this resistance nor alerted public health authorities. A MRSA control program was reported by 55 (61.1%) of the HCFs. The following isolation precautions were routinely used: hospitalization in a private room (34.4%), wearing of gloves (62.2%), wearing of gowns (44.4%), hand washing by healthcare workers (53.3%), use of an isolation sign on the patient's door (43%), or all four. When the characteristics of HCFs with low incidence rates (< 0.4 per 1,000 patient-days) were compared with those of HCFs with high incidence rates (≥ 0.4 per 1,000 patient-days), having a higher mean number of beds per infection control nurse was the only factor significantly associated with HCFs with high incidence rates (834 vs 318 beds; P = .02). CONCLUSION: Our results emphasize the urgent need to strengthen the microbiologic and epidemiologic capacities of HCFs worldwide to prevent MRSA transmission and to prepare them to address the possible emergence of vancomycin-resistant S. aureus.

Original languageEnglish
Pages (from-to)334-341
Number of pages8
JournalInfection Control and Hospital Epidemiology
Volume24
Issue number5
DOIs
StatePublished - 1 May 2003

Fingerprint

Dive into the research topics of 'Are there regional variations in the diagnosis surveillance, and control of methicillin-resistant Staphylococcus aureus?'. Together they form a unique fingerprint.

Cite this